Clinical Trial Update: A Study to Find the Best Dose of BI 836880 Alone and in Combination With BI 754091 in Japanese Patients With Different Types of Advanced Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial to determine the best dose of BI 836880 alone and in combination with BI 754091 in Japanese patients with advanced cancer; results have been poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• BI 836880
• BI-754091

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2025-10-06